If the Price is Right – Cost Effectiveness – by PSY-23
What we have begun to see is a geographical division in the availability of care packages dependant on your address
Scheduling of Cannabis-derived medicinal products
“The ACMD agrees with the Chief Medical Officer for England (CMO) that there is now evidence of medicinal benefit for some Cannabis-derived products in certain medical conditions for some patients.”
California issues guidance following CBD questions
The Controlled Substances Act of 1970 classified all forms of cannabis as a Schedule I drug, making it illegal to grow it in the United States.3
Brain changes responsible for the appetite effects of cannabis are identified in animal studies
“We found that cannabis exposure caused more frequent, small meals,”
The Revolutionary Healing Potential of Entheogenic and Psychedelic Medicines
“It’s designed to bring people together to hear uplifting messages about healing from experts in the field of natural entheogenic and psychedelic medicines, to connect with one another and to feel free… this is awakening to our true nature as human beings.”
Legal – ish. Uk frustrated by division of opinion – By PSY 23
The fight goes on, but at least we may have a few more allies as we push forward.
Glorified High – Those who are against will cry from the roof tops – By PSY 23
Maybe…but probably not.
Senzer Plans to Launch Its Inhaled Cannabinoid Products in the UK
“We hope that this will be a new and meaningful treatment option available on prescription and increase the range of options for doctors and patients alike as they navigate their cancer care.”
Cannabium’s founders’ goal is to transform cannabis commodities trading
I’m involved in the Israeli medicinal cannabis industry from its infancy and actively been developing technologies for products and projects worldwide
It may be unorthodox but the treatment is working for Quebec’s shelters animals
“It’s already a billion-dollar industry in the U.S.,”